Showing 71-80 of 7431 results for "".
Enstilar Approved; New Data for Otezla, Duac
https://practicaldermatology.com/topics/psoriasis/dermwiretv-enstilar-approved-new-data-for-otezla-duac/18687/LEO Pharma's Enstilar (Calcipotriene and Betamethasone Dipropionate) Foam, 0.005%/0.064% has been FDA-approved for plaque psoriasis. New data presented at EADV on Stiefel's Duac, Celgene's Otezla, and Boehringer Ingelheim's investigational biologic compound BI 655066. Plus, Galderma's OTC Excipial lThe State of Academic Dermatology
https://practicaldermatology.com/topics/practice-management/the-state-of-academic-dermatology/18843/In this edition of Derm Insider, host Neal Bhatia, MD sits down with Jane Grant-Kels, MD, Sheila Fallon Friedlander, MD, and Kevin Cooper, MD to discuss the challenges and rewards of academic dermatology. From meeting aggressive budgets to dealing with EMRs, academicians face many of the same demandAssessing the Aging Face
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/assessing-the-aging-face/18849/Jason Emer, MD discusses the evolving filler market and new trends in facial rejuvenation treatments. He offers tips for assessing patients globally—in three and four dimensions—in order to choose the right options for contouring the face with fillers and fat in order to give patients the most naturLet's Talk about YouTube and why your Practice should have one
https://practicaldermatology.com/topics/practice-management/let-s-talk-about-youtube-and-why-your-practice-should-have-one/19116/Any form of healthcare, dental and veterinarian practice should have a YouTube account. It is known that people prefer to watch a video to learn and understand something, rather than read an article or look at a picture. YouTube gives your practice the chance to educate your patients or clients.DermwireTV — Bayer Buys Merck’s OTC Lines, Allergan Rejects Valeant Bid
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-bayer-buys-merck-rsquo-s-otc-lines-allergan-rejects-valeant-bid/19134/Bayer Purchases Merck's OTC Products and Allergan Rebuffs Valeant. This week DermWireTV explores Bayer's growth in the OTC space, including sunscreens, and reports new data on skin cancer mortality. Also in this edition: Neal Bhatia, MD reviews the Noah Worcester Society Annual Meeting.Topical Management of Acne-related Post-inflammatory Hyperpigmentation
https://practicaldermatology.com/topics/general-topics/topical-management-of-acne-related-post-inflammatory-hyperpigmentation/21571/Patient education and continued treatment of underlying acne is essential to ensure optimal outcomes with PIH.Update on Oral Contraceptive Therapy in Acne
https://practicaldermatology.com/topics/general-topics/update-on-oral-contraceptive-therapy-in-acne/21582/While OCPs can be effective against acne, it is important to understand the risks and identify ideal candidates for therapy.Advances in Cosmeceuticals and Makeup – State of the Art from the Innovators
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/advances-in-cosmeceuticals-and-makeup--state-of-the-art-from-the-innovators/21607/Experts from different arenas in cosmetic dermatology weigh in on current and future developments.Rosacea Therapy: Current Approaches and Future Directions
https://practicaldermatology.com/topics/general-topics/rosacea-therapy-current-approaches-and-future-directions/21610/New topical formulations in development may become the first treatments approved for the reduction of erythema associated with rosacea.Update on the Treatment of Actinic Keratoses
https://practicaldermatology.com/topics/general-topics/update-on-the-treatment-of-actinic-keratoses/21630/From mainstay therapies to newly approved agents, treatment options for actinic keratoses are growing.